In a CHOP-led study, researchers found a dramatic drop across the lifespan during the early pandemic, as well as a decrease in sites providing pediatric vaccinations.

CHOP recognized by the National Organization on Disability at annual forum, which brings together global CEOs, celebrities and policy influencers to reimagine the future of the workplace.

The goal of this “deimplementation” study is to reduce risk while aligning practice with the best available evidence.

The Mitochondria and Cancer Connections (MC²) Research Program will study how cancer cells find the energy to grow and ways to prevent their return.

For children under 5, a high fever can trigger a seizure. Find out how to identify a seizure and keep your child safe.

New patient handout provides clinicians with quick-hit details about current strengths and challenges for children with Down syndrome.

Trisomy 21 Program staff provide details on the joys and challenges of raising a child with Down syndrome to help genetic counselors better prepare families.

Fainting spells can sometimes be the first warning sign of undiagnosed heart disease. A CHOP expert explains what to look out for and when to call your pediatrician.

Ryosuke (Roy) Takei, MD, is the Medical Director of Pediatric Hospital Medicine for CHOP’s new King of Prussia Hospital. 

CHOP researchers participated in clinical trial that showed valsartan has a measurable benefit for patients with early-stage hypertrophic cardiomyopathy.